Authors' Affiliations: 1 Department of Developmental, Molecular and Chemical Biology 8 Tufts University School of Medicine; Sackler School of Graduate Biomedical Sciences, Tufts 9 University; Department of Cancer Biology, Dana-Farber Cancer Institute; Department of 10 Biological Chemistry and Molecular Pharmacology; , 6 Department of Biochemistry, University 11 of Kashmir, Kashmir, India; 7 Dep...

Leigh Ellis and Massimo Loda Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263; Department of Medical Oncology, Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA 02115; Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana–Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, MA 02115...

Proposed Investigators: Tara Henderson* [email protected] University of Chicago Chaya Moskowitz* [email protected] Memorial Sloan Kettering Cancer Center Joanne Chou [email protected] Memorial Sloan Kettering Cancer Center David Hodgson [email protected] Princess Margaret Hospital Rebecca Howell [email protected] MD Anderson Cancer Center Lisa Diller [email protected]...

Department of Medical Oncology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA; ActivX Biosciences, Inc., La Jolla, CA; Lurie Family Imaging Center, Dana-Farber Cancer Institute, MA; Chemical Kinomics Research Center, Korea Institute of Science...

S. Williams1, I.D. Davis2, C. Sweeney3, M.R. Stockler4, A. Martin4, A.P. Long4, S. Yip4, X. Coskinas4, P. Nguyen5 Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, AUSTRALIA Eastern Health Clinical School, Monash University, Melbourne, VIC, AUSTRALIA Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, USA NHMRC Clinical Trials Centre, University of...

Correspondence: Ann S. LaCasce, M.D., Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA. Telephone: 617-632-5959 Fax: 617-632-5890; e-mail: [email protected] Received March 20, 2006; accepted for publication April 11, 2006. ©AlphaMed Press 1083-7159/2006/$20.00/0 Abstract Post-transplant lymphoproliferative disorder is the most common malignancy, with t...

For helpful comments and suggestions, we wish to thank Alan Garber, Dana Goldman, Geoffrey Joyce, Tomas Philipson, participants in the 2005 NBER Summer Institute Health Economics Workshop, and participants in the Fall 2006 NBER Health Care Program Meetings. We are grateful to the National Institute on Aging for funding. The views expressed herein are those of the author(s) and do not necessaril...

The statistical models of discrimination we covered previously were static models. In contrast, Altonji and Pierret (2001) use a dynamic model of employer learning to develop a test of statistical discrimination by firms. The theoretical underpinnings of their paper build closely on the paper by Farber and Gibbons (1996). Before discussing Altonji and Pierret (2001), we are first going to walk ...